Mylan (MYL), Theravance Biopharma(TBPH) Announce Positive Data from Two Revefenacin Phase 3s as COPD Treatment
Tweet Send to a Friend
Theravance Biopharma, Inc. (Nasdaq: TBPH) and Mylan N.V. (Nasdaq: MYL) announced positive results from two replicate Phase 3 efficacy studies ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
